General Information of Drug (ID: DMFHR2O)

Drug Name
XR-1853 Drug Info
Synonyms XR 1853; XR-1853; AC1O5RT5; 3-((4-(2-(Dimethylamino)ethoxy)phenyl)methylene)-6-(phenylmethylene)-2,5-piperazinedione; 158944-02-6
Indication
Disease Entry ICD 11 Status REF
Thrombosis DB61-GB90 Terminated [1]
Cross-matching ID
PubChem CID
6439506
CAS Number
CAS 158944-02-6
TTD Drug ID
DMFHR2O

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Discontinued Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Aleplasinin DMYTIP4 Alzheimer disease 8A20 Phase 1 [3]
T-686 DMOGQ2L Arteriosclerosis BD40 Terminated [4]
XR-5082 DMEVSZO Thrombosis DB61-GB90 Terminated [5]
BX-044 DM0P8CE Thrombosis DB61-GB90 Terminated [6]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Plasminogen activator inhibitor (PAI) TT5QA2I PAI1_HUMAN; PAI2_HUMAN; IPSP_HUMAN Modulator [2]

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800006899)
2 Characterization and comparative evaluation of a novel PAI-1 inhibitor. Thromb Haemost. 2002 Jul;88(1):137-43.
3 CN patent application no. 102046168, Pai-1 expression and activity inhibitors for the treatment of ocular disorders.
4 T-686, a novel inhibitor of plasminogen activator inhibitor-1, inhibits thrombosis without impairment of hemostasis in rats. Eur J Pharmacol. 1997 Jul 9;330(2-3):151-6.
5 Evaluation of a low molecular weight modulator of human plasminogen activator inhibitor-1 activity. Thromb Haemost. 1996 May;75(5):808-15.
6 Characterization of a small molecule PAI-1 inhibitor, ZK4044. Thromb Res. 2005;115(4):341-50.